It has been observed that lymphangiogenic growth factors (e.g., VEGF-C, VEGF-D, PDGF-BB, FGF2, S1P) released by both cancer cells and tumor microenvironment mediate the formation of novel LVs and the dilatation of vessel lumen in different primary tumors [2,4]. The gene discussed is VEGFC; the disease is cancer.